📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Transition Therapeutics

1.1 - Company Overview

Transition Therapeutics Logo

Transition Therapeutics

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical therapeutics targeting disease indications with large markets. Lead products include ELND005 for the treatment of Alzheimer’s disease and TT223 for the treatment of diabetes, with an emerging pipeline of preclinical drug candidates acquired externally.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Transition Therapeutics

Coaxia Logo

Coaxia

HQ: United States Website
  • Description: Provider of medical device research and development focused on therapy and treatment solutions for cerebral ischemia; based in Minneapolis, MN.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Coaxia company profile →
Cadent Therapeutics Logo

Cadent Therapeutics

HQ: United States Website
  • Description: Provider of novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease, leveraging a precision neuroscience approach combining target specificity, patient selection, and drug design and optimization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cadent Therapeutics company profile →
Eleusian Biosciences Logo

Eleusian Biosciences

HQ: Canada Website
  • Description: Provider of therapeutics in development for multiple pathological psychological diseases, based on psilocybin plus N-acetylcysteine (NAC) compounds.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eleusian Biosciences company profile →
Statera Spine Logo

Statera Spine

HQ: United States Website
  • Description: Provider of software-enabled spine imaging analytics solutions for chronic and acute spine issues, offering diagnostic and decision-making tools including Profile-ESP for standardized spinal motion and alignment data reports, and VMA, a fluoroscopy imaging system assessing spinal instability and sagittal alignment with measurements for surgical decisions and insurance disputes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Statera Spine company profile →
Avid Radiopharmaceuticals Logo

Avid Radiopharmaceuticals

HQ: United States Website
  • Description: Provider of molecular imaging agents to aid detection and monitoring of chronic human diseases. Products include FDA-approved PET imaging agents: Amyvid for detecting beta-amyloid plaques in the brain and Tauvid for detecting tau pathology in patients evaluated for Alzheimer's disease. Based in Philadelphia, PA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avid Radiopharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Transition Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Transition Therapeutics

2.2 - Growth funds investing in similar companies to Transition Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Transition Therapeutics

4.2 - Public trading comparable groups for Transition Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Transition Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Transition Therapeutics

What does Transition Therapeutics do?

Transition Therapeutics is a provider of biopharmaceutical therapeutics targeting disease indications with large markets. Lead products include ELND005 for the treatment of Alzheimer’s disease and TT223 for the treatment of diabetes, with an emerging pipeline of preclinical drug candidates acquired externally.

Who are Transition Therapeutics's competitors?

Transition Therapeutics's competitors and similar companies include Coaxia, Cadent Therapeutics, Eleusian Biosciences, Statera Spine, and Avid Radiopharmaceuticals.

Where is Transition Therapeutics headquartered?

Transition Therapeutics is headquartered in Canada.

How many employees does Transition Therapeutics have?

Transition Therapeutics has 1,000 employees 🔒.

When was Transition Therapeutics founded?

Transition Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Transition Therapeutics in?

Transition Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Transition Therapeutics

Who are the top strategic acquirers in Transition Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Transition Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Transition Therapeutics?

Top strategic M&A buyers groups and sectors for Transition Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Transition Therapeutics's sector and industry vertical

Which are the top PE firms investing in Transition Therapeutics's sector and industry vertical?

Top PE firms investing in Transition Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Transition Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Transition Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Transition Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Transition Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Transition Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Transition Therapeutics?

The key public trading comparables and valuation benchmarks for Transition Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Transition Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Transition Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Transition Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Transition Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Transition Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Transition Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Transition Therapeutics